These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37968313)

  • 21. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Toll-like receptor 10 in modulation of trained immunity.
    Mourits VP; Arts RJW; Novakovic B; Matzaraki V; de Bree LCJ; Koeken VACM; Moorlag SJCFM; van Puffelen JH; Groh L; van der Heijden CDCC; Keating ST; Netea MG; Oosting M; Joosten LAB
    Immunology; 2020 Mar; 159(3):289-297. PubMed ID: 31671203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of sex hormones on BCG-induced trained immunity.
    de Bree LCJ; Janssen R; Aaby P; van Crevel R; Joosten LAB; Benn CS; Netea MG
    J Leukoc Biol; 2018 Sep; 104(3):573-578. PubMed ID: 30153369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes.
    Bekkering S; Blok BA; Joosten LA; Riksen NP; van Crevel R; Netea MG
    Clin Vaccine Immunol; 2016 Dec; 23(12):926-933. PubMed ID: 27733422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.
    Arts RJW; Moorlag SJCFM; Novakovic B; Li Y; Wang SY; Oosting M; Kumar V; Xavier RJ; Wijmenga C; Joosten LAB; Reusken CBEM; Benn CS; Aaby P; Koopmans MP; Stunnenberg HG; van Crevel R; Netea MG
    Cell Host Microbe; 2018 Jan; 23(1):89-100.e5. PubMed ID: 29324233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and β-glucan.
    Namakula R; de Bree LCJ; A Tvedt TH; Netea MG; Cose S; Hanevik K
    PLoS One; 2020; 15(2):e0229287. PubMed ID: 32084227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trained immunity: implications for vaccination.
    Geckin B; Konstantin Föhse F; Domínguez-Andrés J; Netea MG
    Curr Opin Immunol; 2022 Aug; 77():102190. PubMed ID: 35597182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp.
    Silva MVT; Dos Santos JC; Figueiredo AMB; Teufel LU; Pereira JX; Matos GG; Pinto SA; Netea MG; Gomes RS; Joosten LAB; Ribeiro-Dias F
    Microb Pathog; 2021 Sep; 158():105088. PubMed ID: 34260904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity.
    Li W; Moorlag SJCFM; Koeken VACM; Röring RJ; de Bree LCJ; Mourits VP; Gupta MK; Zhang B; Fu J; Zhang Z; Grondman I; van Meijgaarden KE; Zhou L; Alaswad A; Joosten LAB; van Crevel R; Xu CJ; Netea MG; Li Y
    Cell Rep; 2023 May; 42(5):112487. PubMed ID: 37155329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections.
    de Araujo ACVSC; Mambelli F; Sanches RO; Marinho FV; Oliveira SC
    Pathogens; 2023 Nov; 12(12):. PubMed ID: 38133271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trained immunity: consequences for the heterologous effects of BCG vaccination.
    Kleinnijenhuis J; van Crevel R; Netea MG
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):29-35. PubMed ID: 25573107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alendronate modulates cytokine responses in healthy young individuals after BCG vaccination.
    Bulut O; Kilic G; Debisarun PA; Röring RJ; Sun S; Kolkman M; van Rijssen E; Ten Oever J; Koenen H; Barreiro L; Domínguez-Andrés J; Netea MG
    Immunol Lett; 2024 Jun; 267():106851. PubMed ID: 38479480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-Guérin.
    Xu JC; Wu K; Ma RQ; Li JH; Tao J; Hu Z; Fan XY
    BMC Microbiol; 2024 Apr; 24(1):130. PubMed ID: 38643095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19.
    Zapolnik P; Kmiecik W; Mazur A; Czajka H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of vaccine non-specific effects on licensure of new vaccines.
    Munkwase G
    Vaccine; 2024 Feb; 42(5):1013-1021. PubMed ID: 38242737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery.
    Baydemir I; Dulfer EA; Netea MG; Domínguez-Andrés J
    Clin Immunol; 2024 Apr; 261():109930. PubMed ID: 38342415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.